Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies

*Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland, OH; and

†Department of Cardiovascular Medicine, Heart, Vascular & Thoracic Institute, Cleveland Clinic, Cleveland, OH.

Correspondence: Sathyamangla V. Naga Prasad, PhD, FAHA, Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 (e-mail: [email protected]).

We thank Cleveland Clinic Research Programs Committee for funding of clinical study that procured the samples. This work was supported by NIH Grants R01HL103931 and R01HL126827 to WHWT, NIH Grants R01HL089473 and RO1HL128382 to SVNP, and the Cleveland Clinic Research Center for Excellence IF110167 (W.W.H.T. & S.V.N.P.).

The authors report no conflicts of interest.

留言 (0)

沒有登入
gif